1-[4-(2-甲基苯甲酰胺基)苯甲酰基]-5-氧代-2,3,4,5-四氢-1H-1-苯并氮杂卓
更新时间：2025-08-27 21:14:36
![1-[4-(2-甲基苯甲酰胺基)苯甲酰基]-5-氧代-2,3,4,5-四氢-1H-1-苯并氮杂卓结构式](https://image.chemsrc.com/caspic/345/137976-61-5.png)
1-[4-(2-甲基苯甲酰胺基)苯甲酰基]-5-氧代-2,3,4,5-四氢-1H-1-苯并氮杂卓结构式
|
常用名 | 1-[4-(2-甲基苯甲酰胺基)苯甲酰基]-5-氧代-2,3,4,5-四氢-1H-1-苯并氮杂卓 | 英文名 | 2-Methyl-N-{4-[(5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)car bonyl]phenyl}benzamide |
|---|---|---|---|---|
| CAS号 | 137976-61-5 | 分子量 | 398.45400 | |
| 密度 | 1.27 | 沸点 | 553.103ºC at 760 mmHg | |
| 分子式 | C25H22N2O3 | 熔点 | N/A | |
| MSDS | N/A | 闪点 | 288.307ºC |
| 中文名 | 1-[4-(2-甲基苯甲酰胺基)苯甲酰基]-5-氧代-2,3,4,5-四氢-1H-1-苯并氮杂卓 |
|---|---|
| 英文名 | 2-Methyl-N-{4-[(5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)car bonyl]phenyl}benzamide |
| 英文别名 | 更多 |
| 密度 | 1.27 |
|---|---|
| 沸点 | 553.103ºC at 760 mmHg |
| 分子式 | C25H22N2O3 |
| 分子量 | 398.45400 |
| 闪点 | 288.307ºC |
| 精确质量 | 398.16300 |
| PSA | 66.48000 |
| LogP | 5.00860 |
| InChIKey | VQGMMQBJIJUSEG-UHFFFAOYSA-N |
| SMILES | Cc1ccccc1C(=O)Nc1ccc(C(=O)N2CCCC(=O)c3ccccc32)cc1 |
|
~%
1-[4-(2-甲基苯甲酰胺基... 137976-61-5 |
| 文献：Ogawa, Hidenori; Yamashita, Hiroshi; Kondo, Kazumi; Yamamura, Yoshitaka; Miyamoto, Hisashi; Kan, Keizo; Kitano, Kazuyoshi; Tanaka, Michinori; Nakaya, Kenji; Nakamura, Shigeki; Mori, Toyoki; Tominaga, Michiaki; Yabuuchi, Youichi Journal of Medicinal Chemistry, 1996 , vol. 39, # 18 p. 3547 - 3555 |
|
~%
1-[4-(2-甲基苯甲酰胺基... 137976-61-5 |
| 文献：Ogawa, Hidenori; Yamashita, Hiroshi; Kondo, Kazumi; Yamamura, Yoshitaka; Miyamoto, Hisashi; Kan, Keizo; Kitano, Kazuyoshi; Tanaka, Michinori; Nakaya, Kenji; Nakamura, Shigeki; Mori, Toyoki; Tominaga, Michiaki; Yabuuchi, Youichi Journal of Medicinal Chemistry, 1996 , vol. 39, # 18 p. 3547 - 3555 |
|
~%
1-[4-(2-甲基苯甲酰胺基... 137976-61-5 |
| 文献：Ogawa, Hidenori; Yamashita, Hiroshi; Kondo, Kazumi; Yamamura, Yoshitaka; Miyamoto, Hisashi; Kan, Keizo; Kitano, Kazuyoshi; Tanaka, Michinori; Nakaya, Kenji; Nakamura, Shigeki; Mori, Toyoki; Tominaga, Michiaki; Yabuuchi, Youichi Journal of Medicinal Chemistry, 1996 , vol. 39, # 18 p. 3547 - 3555 |
|
~%
1-[4-(2-甲基苯甲酰胺基... 137976-61-5 |
| 文献：Yamanouchi Pharmaceutical Co., Ltd. Patent: US5723606 A1, 1998 ; |
![1,2,3,4-四氢-苯并[b]氮杂卓-5-酮结构式](https://image.chemsrc.com/caspic/496/1127-74-8.png)
![1-(4-氨基苯甲酰基)-2,3,4,5-四氢苯并[b]氮杂卓-5-酮结构式](https://image.chemsrc.com/caspic/283/137976-09-1.png)
| 1,3-dimethyl-5-oxo-cyclohexanecarbonitrile |
| 1,3-Dimethyl-5-oxo-cyclohexancarbonitril |
| 2-methyl-4'-[(5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepin-1-yl)carbonyl]benzanilide |
| 2-methyl-4'-(5-oxo-2,3,4,5-tetrahydro-1H-1-benzoazepine-1-carbonyl)benzanilide |
| 5-Oxo-1.3-dimethyl-cyclohexan-carbonsaeure-(1)-nitril |
| 5-oxo-1-[4-(2-methylbenzoylamino)benzoyl]-2,3,4,5-tetrahydro-1H-benzazepine |
| 1.3-Dimethyl-1-cyan-cyclohexanon-(5) |
本网页内容来自不同专业数据源，如对内容有疑义，欢迎联系service1@chemsrc.com。
